Chargement en cours...
Combination of mTOR and MAPK Inhibitors—A Potential Way to Treat Renal Cell Carcinoma
Renal cell carcinoma (RCC) is the most common neoplasm that occurs in the kidney and is marked by a unique biology, with a long history of poor response to conventional cancer treatments. In the past few years, there have been significant advancements to understand the biology of RCC. This has led t...
Enregistré dans:
| Publié dans: | Med Sci (Basel) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635794/ https://ncbi.nlm.nih.gov/pubmed/29083380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci4040016 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|